Kuros Biosurgery Completes Merger With Cytos Biotechnology

Kuros Biosurgery closed the transaction merging Kuros with Cytos Biotechnology, originally announced at the end of 4Q15.

The combined entity, Kuros Biosciences, will continue development of orthobiologic products such as KUR-111 and KUR-113, designed to generate bone tissue to heal...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us